| ID | 1694 |
|---|
| No | 1694 |
|---|
| Brand Name | LUCIBOSE |
|---|
| Ingredients | BOSENTAN 125 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 56'S/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN ADULT TO IMPROVE EXCERCISE ABILITY AND TO DECREASE CLINICAL WORSENING, IN PEDIATRIC PTIENTS AGED 3 YEARS AND OLDER WITH IDIOPATHIC OR CONGENITAL PAH TO IMPROVE PULMONARY VASCULAR RESISTANC WHICH IS EXPECTED TO RESULT IN AN IMPROVEMENT IN EXCERCISE ABILITY |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | PINK ROUND TABLET, WITH LETTER LUS ON ONE SIDE AND PLAIN ON THE OTHER SIDE |
|---|
| Note | |
|---|
| License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 L 1319/25 |
|---|
| FDD Registration Date | 07/04/2025 |
|---|
| Expiry Date | 06/04/2030 |
|---|
